PT Kalbe Farma Tbk (PTKFF)
0.0926
0.00 (0.00%)
USD |
OTCM |
May 22, 16:00
PT Kalbe Farma Gross Profit Margin (Quarterly): 39.71% for March 31, 2024
Gross Profit Margin (Quarterly) Chart
Historical Gross Profit Margin (Quarterly) Data
| Date | Value |
|---|---|
| March 31, 2024 | 39.71% |
| December 31, 2023 | 36.97% |
| September 30, 2023 | 37.00% |
| June 30, 2023 | 40.44% |
| March 31, 2023 | 40.92% |
| December 31, 2022 | 38.30% |
| September 30, 2022 | 40.18% |
| June 30, 2022 | 41.83% |
| March 31, 2022 | 41.75% |
| December 31, 2021 | 41.95% |
| September 30, 2021 | 42.83% |
| June 30, 2021 | 43.28% |
| March 31, 2021 | 44.01% |
| December 31, 2020 | 41.13% |
| September 30, 2020 | 45.87% |
| June 30, 2020 | 45.37% |
| March 31, 2020 | 45.16% |
| December 31, 2019 | 42.71% |
| September 30, 2019 | 45.79% |
| June 30, 2019 | 46.09% |
| March 31, 2019 | 46.55% |
| December 31, 2018 | 43.81% |
| September 30, 2018 | 47.00% |
| June 30, 2018 | 47.82% |
| March 31, 2018 | 48.42% |
| Date | Value |
|---|---|
| December 31, 2017 | 48.08% |
| September 30, 2017 | 48.55% |
| June 30, 2017 | 48.65% |
| March 31, 2017 | 49.21% |
| December 31, 2016 | 49.09% |
| September 30, 2016 | 49.20% |
| June 30, 2016 | 49.32% |
| March 31, 2016 | 48.21% |
| December 31, 2015 | 45.82% |
| September 30, 2015 | 47.94% |
| June 30, 2015 | 49.09% |
| March 31, 2015 | 49.50% |
| December 31, 2014 | 50.86% |
| September 30, 2014 | 48.38% |
| June 30, 2014 | 47.94% |
| March 31, 2014 | 47.82% |
| December 31, 2013 | 46.20% |
| September 30, 2013 | 48.49% |
| June 30, 2013 | 49.21% |
| March 31, 2013 | 48.37% |
| December 31, 2012 | 45.93% |
| September 30, 2012 | 48.10% |
| June 30, 2012 | 49.13% |
| March 31, 2012 | 48.98% |
| December 31, 2011 | 48.59% |
Gross Profit Margin Definition
Gross Profit Margin is calculated using Gross Profit/Revenue. This metric measures the overall efficiency of a company in being able to turn revenue into gross profit and doing this by keeping cost of goods sold low. An analyst looking at gross profit margin might look for a higher gross profit margin relative to other comparable companies as well as a gross profit margin that is growing.
Gross Profit Margin (Quarterly) Range, Past 5 Years
36.97%
Minimum
Dec 2023
46.09%
Maximum
Jun 2019
42.06%
Average
41.89%
Median
Gross Profit Margin (Quarterly) Benchmarks
| Taihe Group Inc | -- |
| CEL-SCI Corp | -- |
| AIM ImmunoTech Inc | 80.00% |
| IGC Pharma Inc | 65.20% |
| NovaBay Pharmaceuticals Inc | 68.19% |
Gross Profit Margin (Quarterly) Related Metrics
| Return on Equity | 12.55% |
| Return on Assets | 10.33% |
| Return on Invested Capital | 12.03% |
| Profit Margin (Quarterly) | 11.45% |
| Operating Margin (Quarterly) | 14.62% |
| Return on Net Operating Assets | 11.57% |